A detailed history of Gordian Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gordian Advisors LLC holds 4,394 shares of JNJ stock, worth $876,954. This represents 0.55% of its overall portfolio holdings.

Number of Shares
4,394
Previous 4,390 0.09%
Holding current value
$876,954
Previous $671 Million 21.5%
% of portfolio
0.55%
Previous 0.48%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$155.17 - $185.42 $620 - $741
4 Added 0.09%
4,394 $815 Million
Q2 2025

Jul 25, 2025

BUY
$146.36 - $159.82 $146,945 - $160,459
1,004 Added 29.65%
4,390 $671 Million
Q1 2025

Apr 30, 2025

BUY
$142.06 - $167.7 $568 - $670
4 Added 0.12%
3,386 $561 Million
Q4 2024

Feb 05, 2025

BUY
$143.34 - $165.86 $716 - $829
5 Added 0.15%
3,382 $489 Million
Q3 2024

Oct 30, 2024

BUY
$145.48 - $167.38 $491,285 - $565,242
3,377 New
3,377 $547 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gordian Advisors LLC Portfolio

Follow Gordian Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gordian Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gordian Advisors LLC with notifications on news.